Advertisement
Advertisement
ACHV
Achieve Life Sciences, Inc.
2.83
USDSponsored
+0.02
+0.53%
Mar 26, 14:25 UTC -4
Open
ACHV Earnings Reports
Positive Surprise Ratio
ACHV beat 18 of 34 last estimates.
53%
Next Report
Date of Next Report
May 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/-$0.31
Implied change from Q4 25 (Revenue/ EPS)
--
/+10.71%
Implied change from Q1 25 (Revenue/ EPS)
--
/-16.22%
Achieve Life Sciences, Inc. earnings per share and revenue
On Mar 24, 2026, ACHV reported earnings of -0.28 USD per share (EPS) for Q4 25, missing the estimate of -0.27 USD, resulting in a -1.12% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.72% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of -0.31 USD, with revenue projected to reach -- USD, implying an increase of 10.71% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Theravance Biopharma, Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
$1.24
Actual
$0.21
Surprise
-83.12%
Context Therapeutics Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.14
Surprise
-29.39%
Avalo Therapeutics, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$1.49
Actual
-$1.12
Surprise
+24.33%
Journey Medical Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.04
Surprise
+31.86%
Surrozen, Inc. Common
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$1.21
Actual
-Surprise
-
Pyxis Oncology, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.34
Actual
-$0.28
Surprise
+15.55%
Acrivon Therapeutics, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.47
Actual
-$0.52
Surprise
-9.34%
Fractyl Health, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
$0.15
Surprise
+181.70%
NRX Pharmaceuticals, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.01
Surprise
-361.54%
Talphera, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.06
Surprise
+26.47%
FAQ
What were Achieve Life Sciences, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Achieve Life Sciences, Inc. reported EPS of -$0.28, missing estimates by -1.12%, and revenue of $0.00, 0% as expectations.
How did the market react to Achieve Life Sciences, Inc.'s Q4 2025 earnings?
The stock price moved up 0.72%, changed from $4.14 before the earnings release to $4.17 the day after.
When is Achieve Life Sciences, Inc. expected to report next?
The next earning report is scheduled for May 11, 2026.
What are the forecasts for Achieve Life Sciences, Inc.'s next earnings report?
Based on 5
analysts, Achieve Life Sciences, Inc. is expected to report EPS of -$0.31 and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement